FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Entero Healthcare Solutions IPO and JG Chemicals IPO.
Entero Healthcare Solutions IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while JG Chemicals IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Entero Healthcare Solutions IPO | JG Chemicals IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | ICICI Securities Limited Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Jefferies India Private Limited Jm Financial Limited SBI Capital Markets Limited |
Centrum Capital Limited Emkay Global Financial Services Ltd Keynote Financial Services Ltd |
Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Entero Healthcare Solutions IPO is up to ₹1,600.00 Cr whereas the issue size of the JG Chemicals IPO is up to ₹251.19 Cr. The final issue price of Entero Healthcare Solutions IPO is ₹1,258.00 per share and of JG Chemicals IPO is ₹221.00 per share.
Entero Healthcare Solutions IPO | JG Chemicals IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹1,195.00 per share | ₹210.00 per share |
Issue Price (Upper) | ₹1,258.00 per share | ₹221.00 per share |
Issue Price (Final) | ₹1,258.00 per share | ₹221.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹119.00 per share | |
Market Lot Size | 11 shares | 67 shares |
Fresh Issue Size | 79,49,125 shares | 74,66,063 shares |
Fresh Issue Size (Amount) | up to ₹1,000.00 Cr | up to ₹165.00 Cr |
OFS Issue Size | 47,69,475 shares | 39,00,000 shares |
OFS Issue Size (Amount) | up to ₹600.00 Cr | up to ₹86.19 Cr |
Issue Size Total | 1,27,18,600 shares | 1,13,66,063 shares |
Issue Size Total (Amount) | up to ₹1,600.00 Cr | up to ₹251.19 Cr |
Entero Healthcare Solutions IPO opens on Feb 09, 2024, while JG Chemicals IPO opens on Mar 05, 2024. The closing date of Entero Healthcare Solutions IPO and JG Chemicals IPO is Feb 13, 2024, and Mar 07, 2024, respectively.
Entero Healthcare Solutions IPO | JG Chemicals IPO | |
---|---|---|
Anchor Bid Date | Feb 08, 2024 | Mar 04, 2024 |
Issue Open | Feb 09, 2024 | Mar 05, 2024 |
Issue Close | Feb 13, 2024 | Mar 07, 2024 |
Basis Of Allotment (Tentative) | Feb 14, 2024 | Mar 11, 2024 |
Initiation of Refunds (Tentative) | Feb 15, 2024 | Mar 12, 2024 |
Credit of Share (Tentative) | Feb 15, 2024 | Mar 12, 2024 |
Listing date (Tentative) | Feb 16, 2024 | Mar 13, 2024 |
Anchor Lockin End date 1 | Mar 15, 2024 | Apr 10, 2024 |
Anchor Lockin End date 2 | May 14, 2024 | Jun 09, 2024 |
Entero Healthcare Solutions IPO P/E ratio is 0, as compared to JG Chemicals IPO P/E ratio of 16.25.
Entero Healthcare Solutions IPO | JG Chemicals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Entero Healthcare Solutions Limited Financial Information (Restated Consolidated)Entero Healthcare Solutions Limited's revenue increased by 30.84% and profit after tax (PAT) rose by 62.28% between the financial year ending with March 31, 2023 and March 31, 2022.
|
JG Chemicals Limited Financial Information (Restated Consolidated)JG Chemicals Limited's revenue increased by 27.47% and profit after tax (PAT) rose by 31.69% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 77.11% | 100.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 0 | 16.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹3021.21 Cr. | ₹866.01 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | -2.66%% | 8.20%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 6.06%% | 11.86 %% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.45 | 0.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹0.00 | ₹13.60 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | -1.86%% | 8.16%% |
In the Entero Healthcare Solutions IPO retail investors (RII) are offered 13,07,073 shares while in JG Chemicals IPO retail investors are offered 13,07,073 shares. Qualified institutional buyers (QIB) are offered 38,08,069 shares in Entero Healthcare Solutions IPO and 22,73,214 shares in JG Chemicals IPO.
Entero Healthcare Solutions IPO | JG Chemicals IPO | |
---|---|---|
Anchor Investor Reserveration | 56,94,753 shares | 34,09,818 shares |
Market Maker Reserveration | ||
QIB | 38,08,069 shares | 22,73,214 shares |
NII | 19,60,609 shares | 17,04,910 shares |
RII | 13,07,073 shares | 39,78,122 shares |
Employee | 74,349 shares | 0 shares |
Others | ||
Total | 71,50,100 shares | 79,56,246 shares |
Entero Healthcare Solutions IPO subscribed 1.53x in total, whereas JG Chemicals IPO subscribed 28.52x.
Entero Healthcare Solutions IPO | JG Chemicals IPO | |
---|---|---|
QIB (times) | 2.28x | 32.33x |
NII (times) | 0.22x | 47.92x |
Big NII (times) | 0.16x | 50.26x |
Small NII (times) | 0.33x | 43.24x |
RII (times) | 1.33x | 18.03x |
Employee (times) | 1.25x | |
Other (times) | ||
Total (times) | 1.53x | 28.52x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|